Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

LHRH analogue goserelin helps preserve fertility among women undergoing chemo for hormone receptor-negative breast cancer

Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA
LHRH analogue goserelin helps preserve fertility among women undergoing chemo for hormone receptor-negative breast cancer ( Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA )
12 Jun 2014

Investigating anticarcinogenic compounds as an alternative to chemo

Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy
Investigating anticarcinogenic compounds as an alternative to chemo ( Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy )
6 Jun 2014

Importance of oncology nurses' work and research to cancer care

Sarah Liptrott - Eurpean Institute of Oncology, Milan, Italy
Importance of oncology nurses' work and research to cancer care ( Sarah Liptrott - Eurpean Institute of Oncology, Milan, Italy )
6 Jun 2014

Advances in diagnostic devices in melanoma screening

Dr Alessandro Testori - European Institute of Oncology, Milan, Italy
Advances in diagnostic devices in melanoma screening ( Dr Alessandro Testori - European Institute of Oncology, Milan, Italy )
6 Jun 2014

KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second-line treatment of mCC

Prof Marc Peeters - University of Antwerp, Antwerp, Belgium
KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second-line treatment of mCC ( Prof Marc Peeters - University of Antwerp, Antwerp, Belgium )
2 Jun 2014

HPV-targeted adoptive T Cell therapy for advanced cervical cancer

Dr Christian Hinrichs - Center for Cancer Research, Bethesda, USA
HPV-targeted adoptive T Cell therapy for advanced cervical cancer ( Dr Christian Hinrichs - Center for Cancer Research, Bethesda, USA )
2 Jun 2014

PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against metastatic melanoma

Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, US
PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against metastatic melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, US )
2 Jun 2014

Ipilimumab and nivolumab achieves long-term survival in advanced melanoma

Prof Mario Sznol - Yale Cancer Center, New Haven, USA
Ipilimumab and nivolumab achieves long-term survival in advanced melanoma ( Prof Mario Sznol - Yale Cancer Center, New Haven, USA )
2 Jun 2014

Adjuvant ipilimumab improves recurrence-free survival in high-risk stage III melanoma

Prof Alexander M. Eggermont, Erasmus University, Rotterdam, The Netherlands
Adjuvant ipilimumab improves recurrence-free survival in high-risk stage III melanoma ( Prof Alexander M. Eggermont, Erasmus University, Rotterdam, The Netherlands )
2 Jun 2014

HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer

Dr Christian S. Hinrichs - Center for Cancer Research, Bethesda, US
HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer ( Dr Christian S. Hinrichs - Center for Cancer Research, Bethesda, US )
2 Jun 2014

Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

Dr Steven O'Day - Beverly Hills Cancer Center, Los Angeles, USA
Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer ( Dr Steven O'Day - Beverly Hills Cancer Center, Los Angeles, USA )
2 Jun 2014

Comment: Adjuvant ipilimumab in high-risk melanoma

Dr Steven O'Day - Beverly Hills Cancer Center, Los Angeles, USA
Comment: Adjuvant ipilimumab in high-risk melanoma ( Dr Steven O'Day - Beverly Hills Cancer Center, Los Angeles, USA )
2 Jun 2014